Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|YBL-006||YBL006|YBL 006||Immune Checkpoint Inhibitor 146 PD-L1/PD-1 antibody 86||YBL-006 is a monoclonal antibody that binds to PD-1 (PDCD1) and blocks its interaction with PD-L1 (CD274) and PD-L2 (PDCD1LG2), potentially leading to enhanced immune response and inhibition of tumor growth (Cancer Res 2020;80(16 Suppl):Abstract nr 3367).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04450901||Phase I||YBL-006||Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors||Recruiting||3|